The Role of Dapagliflozin in Reducing Anthracycline-Induced Cardiotoxicity in Type 2 Diabetes Mellitus Patients with Breast Cancer

Assessment of Rapamycin effect on apoptosis in MCF-7 breast cancer cell line

Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction Induced Experimentally in Diabetic Rats

Dapagliflozin Ameliorates Glycemic State, Lipid Profile and Renal Functions in Type 2 Diabetic Rats

Sodium glucose transporter 2 inhibitor Dapagliflozin Regulates kisspeptin and GABA receptors mRNA expression in hypothalamic arcuate nucleus in polycystic ovary rat model, Can it

Glucose Transporter 4 and Interleukin 8 expression in hormone receptor-negative/HER2 overexpressing breast carcinoma subtype: Correlation with the biological behavior of the tumor

Potential Cardio-protective Role of Dapagliflozin in Post Myocardial Infarction Patients

Dapagliflozin Versus Insulin: Which Is Better in Treatment of Diabetic Nephropathy in Albino Rats, Immunohistochemical Study

ROSIGLITAZONE SHOWS SEQUENCE-SPECIFIC SYNERGY WITH CHEMOTHERAPEUTIC DRUGS IN INHIBITION OF MCF-7 BREAST CANCER CELL LINE

THE POTENTIAL MODULATING IMPACT OF THE DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR, SITAGLIPTIN ON STREPTOZOTOCIN-NICOTINAMIDE-INDUCED DIABETIC NEPHROPATHY IN RATS